These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28077463)

  • 1. Novel method for detection of glycogen in cells.
    Skurat AV; Segvich DM; DePaoli-Roach AA; Roach PJ
    Glycobiology; 2017 May; 27(5):416-424. PubMed ID: 28077463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and clinical aspects of glycogen storage diseases.
    Ellingwood SS; Cheng A
    J Endocrinol; 2018 Sep; 238(3):R131-R141. PubMed ID: 29875163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Starch Binding Domain-containing Protein 1 Plays a Dominant Role in Glycogen Transport to Lysosomes in Liver.
    Sun T; Yi H; Yang C; Kishnani PS; Sun B
    J Biol Chem; 2016 Aug; 291(32):16479-84. PubMed ID: 27358407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism.
    Jiang S; Heller B; Tagliabracci VS; Zhai L; Irimia JM; DePaoli-Roach AA; Wells CD; Skurat AV; Roach PJ
    J Biol Chem; 2010 Nov; 285(45):34960-71. PubMed ID: 20810658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stbd1 is highly elevated in skeletal muscle of Pompe disease mice but suppression of its expression does not affect lysosomal glycogen accumulation.
    Yi H; Fredrickson KB; Das S; Kishnani PS; Sun B
    Mol Genet Metab; 2013 Jul; 109(3):312-4. PubMed ID: 23726947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in Glycogen Storage Diseases: An Update.
    Molares-Vila A; Corbalán-Rivas A; Carnero-Gregorio M; González-Cespón JL; Rodríguez-Cerdeira C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease.
    Yi H; Sun T; Armstrong D; Borneman S; Yang C; Austin S; Kishnani PS; Sun B
    J Mol Med (Berl); 2017 May; 95(5):513-521. PubMed ID: 28154884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive quantification of α-glucans in mouse tissues, cell cultures, and human cerebrospinal fluid.
    Nitschke S; Petković S; Ahonen S; Minassian BA; Nitschke F
    J Biol Chem; 2020 Oct; 295(43):14698-14709. PubMed ID: 32817315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.
    Sullivan MA; Nitschke S; Skwara EP; Wang P; Zhao X; Pan XS; Chown EE; Wang T; Perri AM; Lee JPY; Vilaplana F; Minassian BA; Nitschke F
    Cell Rep; 2019 Apr; 27(5):1334-1344.e6. PubMed ID: 31042462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glycogenoses--genetic disorders leading to disturbed glycogen metabolism].
    Bejtka M; Malińska D
    Postepy Biochem; 2011; 57(2):148-57. PubMed ID: 21913415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Starch-binding domain-containing protein 1 (Stbd1) and glycogen metabolism: Identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1.
    Jiang S; Wells CD; Roach PJ
    Biochem Biophys Res Commun; 2011 Sep; 413(3):420-5. PubMed ID: 21893048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
    Raben N; Fukuda T; Gilbert AL; de Jong D; Thurberg BL; Mattaliano RJ; Meikle P; Hopwood JJ; Nagashima K; Nagaraju K; Plotz PH
    Mol Ther; 2005 Jan; 11(1):48-56. PubMed ID: 15585405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakdown of lysosomal glycogen in cultured fibroblasts from glycogenosis type II patients after uptake of acid alpha-glucosidase.
    van der Ploeg AT; Kroos M; van Dongen JM; Visser WJ; Bolhuis PA; Loonen MC; Reuser AJ
    J Neurol Sci; 1987 Jul; 79(3):327-36. PubMed ID: 3302116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen metabolism in tissues from a mouse model of Lafora disease.
    Wang W; Lohi H; Skurat AV; DePaoli-Roach AA; Minassian BA; Roach PJ
    Arch Biochem Biophys; 2007 Jan; 457(2):264-9. PubMed ID: 17118331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen phosphorylation and Lafora disease.
    Roach PJ
    Mol Aspects Med; 2015 Dec; 46():78-84. PubMed ID: 26278984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease.
    Duran J; Gruart A; García-Rocha M; Delgado-García JM; Guinovart JJ
    Hum Mol Genet; 2014 Jun; 23(12):3147-56. PubMed ID: 24452334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy.
    Lohi H; Ianzano L; Zhao XC; Chan EM; Turnbull J; Scherer SW; Ackerley CA; Minassian BA
    Hum Mol Genet; 2005 Sep; 14(18):2727-36. PubMed ID: 16115820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between glycogen accumulation and the laforin dual specificity phosphatase.
    Wang W; Parker GE; Skurat AV; Raben N; DePaoli-Roach AA; Roach PJ
    Biochem Biophys Res Commun; 2006 Nov; 350(3):588-92. PubMed ID: 17022935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle glycogenoses.
    DiMauro S; Lamperti C
    Muscle Nerve; 2001 Aug; 24(8):984-99. PubMed ID: 11439374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise in muscle glycogen storage diseases.
    Preisler N; Haller RG; Vissing J
    J Inherit Metab Dis; 2015 May; 38(3):551-63. PubMed ID: 25326273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.